Several studies have described increased EBV reactivation in COVID-19 patients, especially those that are critically ill.26, 27 Paolucci et al.26detected EBV DNA in 95.2% of COVID-19 patients hospitalized in an intensive care unit, as well as significant reductions in CD8+ cells and NK counts. Here, CD8A is linked to COVID-19.